Author: Yuanmei Zhu; Danwei Yu; Hongxia Yan; Huihui Chong; Yuxian He
Title: Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity Document date: 2020_3_28
ID: cogk5kig_1
Snippet: In late December of 2019, a new infectious respiratory disease emerged in Wuhan, China. The 34 pathogen was soon identified as a novel coronavirus (CoV) (1-3), which was initially termed comprises of S1 and S2 subunits and exists in a metastable prefusion conformation. The S1 52 subunit, which contains a receptor-binding domain (RBD) capable of functional folding 53 independently, is responsible for virus binding to the cell surface receptor. A r.....
Document: In late December of 2019, a new infectious respiratory disease emerged in Wuhan, China. The 34 pathogen was soon identified as a novel coronavirus (CoV) (1-3), which was initially termed comprises of S1 and S2 subunits and exists in a metastable prefusion conformation. The S1 52 subunit, which contains a receptor-binding domain (RBD) capable of functional folding 53 independently, is responsible for virus binding to the cell surface receptor. A recent study 54 author/funder. All rights reserved. No reuse allowed without permission.
Search related documents:
Co phrase search for related documents- cell surface and infectious respiratory disease: 1, 2, 3, 4, 5, 6, 7, 8
- cell surface and metastable prefusion conformation: 1
- cell surface and novel coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- cell surface and prefusion conformation: 1, 2, 3, 4, 5, 6, 7, 8
- cell surface and recent study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- cell surface and receptor bind: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
- cell surface and receptor bind domain: 1, 2, 3
- cell surface and respiratory disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60
- cell surface receptor and CoV novel coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- cell surface receptor and infectious respiratory disease: 1, 2, 3, 4
- cell surface receptor and novel coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
- cell surface receptor and prefusion conformation: 1
- cell surface receptor and recent study: 1, 2, 3, 4
- cell surface receptor and receptor bind: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- cell surface receptor and receptor bind domain: 1
- cell surface receptor and respiratory disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- cell surface receptor bind and CoV novel coronavirus: 1
- cell surface receptor bind and novel coronavirus: 1
- cell surface receptor bind and recent study: 1
Co phrase search for related documents, hyperlinks ordered by date